Skip to content

the effect of lentil on dry eye

Comparison of the effect of lentil capsule and placebo on the treatment of dry eye patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014072618600N1
Enrollment
60
Registered
2014-09-27
Start date
2013-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dry eye. Dry eye syndrome

Interventions

Treatment - Drugs
Intervention 1: Intervention: lentil cap containing 200 mg of effective substance of lentil, once a day for 3 month. Intervention 2: control group: placebo cap, once a day for 3 months.
Intervention: lentil cap containing 200 mg of effective substance of lentil, once a day for 3 month
control group: placebo cap, once a day for 3 months

Sponsors

Vice Chancellor for research of Baghiatollah University of Medical Sciencesy of baghiatollah
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 139 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: complaint of foreign body or dry eye and at least in one eye; TUBT score for 3 times after sequential measurements become less than 10 seconds or Schirmer test without topical anesthesia at least in one eye during 5 minutes become less than 10 millimeters or coloring cornea with flourocin at least in one eye; age over 18 years; ability to use capsule; complete the informed consent form; ability to come for follow up exclusion criteria: the Schirmer test be less than 5 millimeters ; TUBT test be less than 5 seconds ;severe corneal coloring ;corneal ulcer at least in that eye ; filamentous keranopathy in that eye ;pregnancy or breast feeding ;any eye Surgery in the last 6 months ;any change in diet in the last month or during treatment ;the use of any topical eye drug during last 7 days in the affected eye ; patients who use topical eye drug due to another eye disease ;people who use contact lens ;use of corticosteroid in the last month ;use of anti-inflammatory drug for eye during last month ;use of corticosteroid or systemic anti-inflammatory drug Simultaneously with treatment ;use of any edible supplement

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The amount of the osmolality of the tear film. Timepoint: at beginning and after 3 month. Method of measurement: measurment via TearLab device.

Secondary

MeasureTime frame
Schirmer 1 test. Timepoint: at beginning and after 3 months. Method of measurement: schirmer paper.;Tear breakup time test. Timepoint: at beginning and after 3 months. Method of measurement: timer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Mehdi Roozbahani

Lorestan University

meroozbeh@yahoo.com+98 66 1423 6573

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026